Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Allylamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110734378B reveals a mild Ni-catalyzed method for high-ee chiral allylamines. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN112010910B details a novel iridium-catalyzed synthesis of chiral ferrocene homoallylamines, offering high yields and enantioselectivity for cost-effective pharmaceutical intermediate manufacturing.
Novel iridium-catalyzed synthesis offers high enantioselectivity for pharmaceutical intermediates. Enhances supply chain reliability and reduces manufacturing costs significantly.
Solve chiral amine synthesis challenges with 99% ee, 1% catalyst loading, and gram-scale production for drug development